Experimental Factor Ontology (EFO) Information | |
Identifier | EFO_0000493 |
Description | Family history is a form of clinicaly history specifically about relevant aspects of genetic preconditions or family member's clinical history. | Trait category |
Other trait
|
Synonym | FamilyHistory |
Mapped terms |
2 mapped terms
|
Child trait(s) | 4 child traits |
Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
---|---|---|---|---|---|---|
PGS001132 (GBE_FH1113) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Family history of chronic bronchitis/emphysema | family history | 1,530 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001132/ScoringFiles/PGS001132.txt.gz |
PGS001292 (GBE_FH1044) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Family history of prostate cancer | family history of prostate cancer | 602 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001292/ScoringFiles/PGS001292.txt.gz |
PGS001324 (GBE_FH1065) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Family history of high blood pressure | family history | 13,862 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001324/ScoringFiles/PGS001324.txt.gz |
PGS001328 (GBE_FH1220) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Family history of diabetes | family history | 2,515 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001328/ScoringFiles/PGS001328.txt.gz |
PGS001337 (GBE_FH1002) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Family history of breast cancer | family history of breast cancer | 195 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001337/ScoringFiles/PGS001337.txt.gz |
PGS001347 (GBE_FH1263) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Family history of Alzheimer's/dementia | family history of Alzheimer’s disease | 139 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001347/ScoringFiles/PGS001347.txt.gz |
PGS001392 (GBE_FH1001) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Family history of lung cancer | family history of lung cancer | 312 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001392/ScoringFiles/PGS001392.txt.gz |
PGS004504 (disease.Z82.score) |
PGP000561 | Jung H et al. Commun Biol (2024) |
Z82 (Family history of certain disabilities and chronic diseases leading to disablement) | family history | 1,059,939 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004504/ScoringFiles/PGS004504.txt.gz |
PGS004574 (meta.Z82.score) |
PGP000561 | Jung H et al. Commun Biol (2024) |
Z82 (Family history of certain disabilities and chronic diseases leading to disablement) | family history | 1,059,939 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004574/ScoringFiles/PGS004574.txt.gz |
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|---|
PPM008388 | PGS001132 (GBE_FH1113) |
PSS004049| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Chronic bronchitis/emphysema (FH) | — | AUROC: 0.55867 [0.53736, 0.57998] | R²: 0.01064 Incremental AUROC (full-covars): -0.00488 PGS R2 (no covariates): 0.00023 PGS AUROC (no covariates): 0.49207 [0.46984, 0.5143] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008389 | PGS001132 (GBE_FH1113) |
PSS004050| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Chronic bronchitis/emphysema (FH) | — | AUROC: 0.59763 [0.55526, 0.63999] | R²: 0.03241 Incremental AUROC (full-covars): 0.00659 PGS R2 (no covariates): 0.00372 PGS AUROC (no covariates): 0.53681 [0.49409, 0.57952] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008390 | PGS001132 (GBE_FH1113) |
PSS004051| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Chronic bronchitis/emphysema (FH) | — | AUROC: 0.5885 [0.58009, 0.59692] | R²: 0.02565 Incremental AUROC (full-covars): 0.00247 PGS R2 (no covariates): 0.00203 PGS AUROC (no covariates): 0.52356 [0.51492, 0.53221] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008391 | PGS001132 (GBE_FH1113) |
PSS004052| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Chronic bronchitis/emphysema (FH) | — | AUROC: 0.54947 [0.53138, 0.56755] | PGS R2 (no covariates): 0.00013 R²: 0.00653 Incremental AUROC (full-covars): -0.00201 PGS AUROC (no covariates): 0.50704 [0.48923, 0.52485] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008392 | PGS001132 (GBE_FH1113) |
PSS004053| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Chronic bronchitis/emphysema (FH) | — | AUROC: 0.58327 [0.57825, 0.58829] | R²: 0.02293 Incremental AUROC (full-covars): 0.0012 PGS R2 (no covariates): 0.00095 PGS AUROC (no covariates): 0.51589 [0.51075, 0.52103] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008958 | PGS001292 (GBE_FH1044) |
PSS004039| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Prostate cancer (FH) | — | AUROC: 0.61052 [0.58828, 0.63276] | R²: 0.03568 Incremental AUROC (full-covars): -0.00159 PGS R2 (no covariates): 0.00029 PGS AUROC (no covariates): 0.5142 [0.49179, 0.53661] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008959 | PGS001292 (GBE_FH1044) |
PSS004040| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Prostate cancer (FH) | — | AUROC: 0.62093 [0.55962, 0.68225] | R²: 0.02796 Incremental AUROC (full-covars): -0.01226 PGS R2 (no covariates): 0.00143 PGS AUROC (no covariates): 0.48253 [0.41865, 0.5464] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008960 | PGS001292 (GBE_FH1044) |
PSS004041| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Prostate cancer (FH) | — | AUROC: 0.56572 [0.5538, 0.57764] | R²: 0.01155 Incremental AUROC (full-covars): 0.01702 PGS R2 (no covariates): 0.00547 PGS AUROC (no covariates): 0.54869 [0.53677, 0.56062] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008961 | PGS001292 (GBE_FH1044) |
PSS004042| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Prostate cancer (FH) | — | AUROC: 0.6064 [0.57694, 0.63587] | R²: 0.02296 Incremental AUROC (full-covars): 0.00822 PGS R2 (no covariates): 0.00335 PGS AUROC (no covariates): 0.54379 [0.5154, 0.57217] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008962 | PGS001292 (GBE_FH1044) |
PSS004043| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Prostate cancer (FH) | — | AUROC: 0.58464 [0.57731, 0.59197] | R²: 0.01828 Incremental AUROC (full-covars): 0.01195 PGS R2 (no covariates): 0.00542 PGS AUROC (no covariates): 0.54716 [0.53996, 0.55435] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009112 | PGS001324 (GBE_FH1065) |
PSS004044| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: High BP (FH) | — | AUROC: 0.59339 [0.57784, 0.60894] | R²: 0.03128 Incremental AUROC (full-covars): -0.00542 PGS R2 (no covariates): 0.00353 PGS AUROC (no covariates): 0.53126 [0.51539, 0.54713] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009113 | PGS001324 (GBE_FH1065) |
PSS004045| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: High BP (FH) | — | AUROC: 0.58604 [0.55827, 0.61382] | R²: 0.03732 Incremental AUROC (full-covars): 0.02078 PGS R2 (no covariates): 0.01267 PGS AUROC (no covariates): 0.55693 [0.52875, 0.58511] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009114 | PGS001324 (GBE_FH1065) |
PSS004046| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: High BP (FH) | — | AUROC: 0.58225 [0.5751, 0.5894] | R²: 0.0275 Incremental AUROC (full-covars): 0.04455 PGS R2 (no covariates): 0.02262 PGS AUROC (no covariates): 0.5748 [0.56762, 0.58198] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009115 | PGS001324 (GBE_FH1065) |
PSS004047| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: High BP (FH) | — | AUROC: 0.59484 [0.58159, 0.6081] | R²: 0.0361 Incremental AUROC (full-covars): 0.0245 PGS R2 (no covariates): 0.01922 PGS AUROC (no covariates): 0.57095 [0.55751, 0.58438] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009116 | PGS001324 (GBE_FH1065) |
PSS004048| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: High BP (FH) | — | AUROC: 0.5865 [0.58217, 0.59084] | R²: 0.03045 Incremental AUROC (full-covars): 0.06315 PGS R2 (no covariates): 0.0284 PGS AUROC (no covariates): 0.58323 [0.57889, 0.58758] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009127 | PGS001328 (GBE_FH1220) |
PSS004054| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Diabetes (FH) | — | AUROC: 0.59818 [0.58435, 0.61201] | R²: 0.0372 Incremental AUROC (full-covars): 0.00441 PGS R2 (no covariates): 0.00401 PGS AUROC (no covariates): 0.53127 [0.51708, 0.54547] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009128 | PGS001328 (GBE_FH1220) |
PSS004055| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Diabetes (FH) | — | AUROC: 0.56465 [0.53655, 0.59276] | R²: 0.02549 Incremental AUROC (full-covars): 0.0225 PGS R2 (no covariates): 0.00709 PGS AUROC (no covariates): 0.53656 [0.50824, 0.56489] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009129 | PGS001328 (GBE_FH1220) |
PSS004056| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Diabetes (FH) | — | AUROC: 0.58763 [0.57927, 0.59598] | R²: 0.02799 Incremental AUROC (full-covars): 0.03336 PGS R2 (no covariates): 0.01623 PGS AUROC (no covariates): 0.56772 [0.55933, 0.57611] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009130 | PGS001328 (GBE_FH1220) |
PSS004057| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Diabetes (FH) | — | AUROC: 0.58336 [0.57075, 0.59597] | R²: 0.03022 Incremental AUROC (full-covars): 0.03694 PGS R2 (no covariates): 0.02309 PGS AUROC (no covariates): 0.57176 [0.55908, 0.58443] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009131 | PGS001328 (GBE_FH1220) |
PSS004058| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Diabetes (FH) | — | AUROC: 0.57463 [0.56952, 0.57975] | R²: 0.01929 Incremental AUROC (full-covars): 0.05803 PGS R2 (no covariates): 0.01839 PGS AUROC (no covariates): 0.57283 [0.56773, 0.57794] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009171 | PGS001337 (GBE_FH1002) |
PSS004034| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Breast cancer (FH) | — | AUROC: 0.57882 [0.5595, 0.59814] | R²: 0.01774 Incremental AUROC (full-covars): 0.00262 PGS R2 (no covariates): 0.00016 PGS AUROC (no covariates): 0.50866 [0.48823, 0.52909] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009172 | PGS001337 (GBE_FH1002) |
PSS004035| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Breast cancer (FH) | — | AUROC: 0.60865 [0.56929, 0.64801] | R²: 0.03344 Incremental AUROC (full-covars): 0.01456 PGS R2 (no covariates): 0.0091 PGS AUROC (no covariates): 0.56734 [0.52563, 0.60905] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009173 | PGS001337 (GBE_FH1002) |
PSS004036| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Breast cancer (FH) | — | AUROC: 0.57917 [0.56994, 0.5884] | R²: 0.01887 Incremental AUROC (full-covars): 0.00313 PGS R2 (no covariates): 0.002 PGS AUROC (no covariates): 0.52353 [0.51419, 0.53286] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009174 | PGS001337 (GBE_FH1002) |
PSS004037| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Breast cancer (FH) | — | AUROC: 0.60464 [0.58531, 0.62397] | R²: 0.02766 Incremental AUROC (full-covars): 0.00261 PGS R2 (no covariates): 0.00157 PGS AUROC (no covariates): 0.52221 [0.5025, 0.54191] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009175 | PGS001337 (GBE_FH1002) |
PSS004038| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Breast cancer (FH) | — | AUROC: 0.57389 [0.56837, 0.57941] | R²: 0.01618 Incremental AUROC (full-covars): 0.00514 PGS R2 (no covariates): 0.0022 PGS AUROC (no covariates): 0.527 [0.52143, 0.53258] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009216 | PGS001347 (GBE_FH1263) |
PSS004059| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Alzheimer's/dementia (FH) | — | AUROC: 0.60815 [0.58401, 0.63228] | R²: 0.02957 Incremental AUROC (full-covars): -0.00275 PGS R2 (no covariates): 0.00019 PGS AUROC (no covariates): 0.50162 [0.47638, 0.52686] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009217 | PGS001347 (GBE_FH1263) |
PSS004060| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Alzheimer's/dementia (FH) | — | AUROC: 0.65316 [0.60391, 0.70242] | R²: 0.05029 Incremental AUROC (full-covars): 0.01325 PGS R2 (no covariates): 0.00988 PGS AUROC (no covariates): 0.55047 [0.49474, 0.60619] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009218 | PGS001347 (GBE_FH1263) |
PSS004061| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Alzheimer's/dementia (FH) | — | AUROC: 0.60962 [0.60006, 0.61918] | R²: 0.03194 Incremental AUROC (full-covars): 0.01629 PGS R2 (no covariates): 0.00825 PGS AUROC (no covariates): 0.55082 [0.5403, 0.56135] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009219 | PGS001347 (GBE_FH1263) |
PSS004062| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Alzheimer's/dementia (FH) | — | AUROC: 0.58721 [0.56379, 0.61063] | R²: 0.01634 Incremental AUROC (full-covars): 0.00317 PGS R2 (no covariates): 0.00225 PGS AUROC (no covariates): 0.52129 [0.49619, 0.5464] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009220 | PGS001347 (GBE_FH1263) |
PSS004063| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Alzheimer's/dementia (FH) | — | AUROC: 0.60904 [0.60337, 0.61471] | R²: 0.03418 Incremental AUROC (full-covars): 0.02436 PGS R2 (no covariates): 0.01188 PGS AUROC (no covariates): 0.55827 [0.55209, 0.56446] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM005195 | PGS001392 (GBE_FH1001) |
PSS004029| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Lung cancer (FH) | — | AUROC: 0.5814 [0.56522, 0.59758] | R²: 0.02252 Incremental AUROC (full-covars): -0.00177 PGS R2 (no covariates): 0.00021 PGS AUROC (no covariates): 0.49231 [0.47576, 0.50886] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM005196 | PGS001392 (GBE_FH1001) |
PSS004030| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Lung cancer (FH) | — | AUROC: 0.585 [0.55514, 0.61486] | R²: 0.02833 Incremental AUROC (full-covars): -0.00236 PGS R2 (no covariates): 0.00024 PGS AUROC (no covariates): 0.4925 [0.46136, 0.52364] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM005197 | PGS001392 (GBE_FH1001) |
PSS004031| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Lung cancer (FH) | — | AUROC: 0.58684 [0.57949, 0.59418] | R²: 0.02847 Incremental AUROC (full-covars): 0.00084 PGS R2 (no covariates): 0.00154 PGS AUROC (no covariates): 0.51927 [0.51173, 0.52681] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM005198 | PGS001392 (GBE_FH1001) |
PSS004032| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Lung cancer (FH) | — | AUROC: 0.55862 [0.54359, 0.57365] | R²: 0.01079 Incremental AUROC (full-covars): -0.0005 PGS R2 (no covariates): 0.0 PGS AUROC (no covariates): 0.50036 [0.48483, 0.51589] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM005199 | PGS001392 (GBE_FH1001) |
PSS004033| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Lung cancer (FH) | — | AUROC: 0.58081 [0.57641, 0.58522] | R²: 0.02597 Incremental AUROC (full-covars): 0.00042 PGS R2 (no covariates): 0.00043 PGS AUROC (no covariates): 0.51047 [0.50596, 0.51498] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM020619 | PGS004504 (disease.Z82.score) |
PSS011364| European Ancestry| 56,192 individuals |
PGP000561 | Jung H et al. Commun Biol (2024) |
Reported Trait: Z82 (Family history of certain disabilities and chronic diseases leading to disablement) | OR: 1.15277 | — | — | — | — |
PPM020689 | PGS004574 (meta.Z82.score) |
PSS011364| European Ancestry| 56,192 individuals |
PGP000561 | Jung H et al. Commun Biol (2024) |
Reported Trait: Z82 (Family history of certain disabilities and chronic diseases leading to disablement) | OR: 1.24248 | — | — | — | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS004029 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004030 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004031 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004032 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004033 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS004034 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004035 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004036 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004037 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004038 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS004039 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004040 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004041 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004042 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004043 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS004044 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004045 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004046 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004047 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004048 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS004049 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004050 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004051 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004052 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004053 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS004054 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004055 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004056 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004057 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004058 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS004059 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004060 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004061 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004062 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004063 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS011364 | — | — | 56,192 individuals | — | European | — | UKB | — |